Inequality in Cancer Care is Costing Lives
The Swedish Institute for Health Economics (IHE) and PhRMA MEA announce findings of their key report that explores the cancer care landscape in nine Middle Eastern and African countries.
Cancer Care in the Middle East and Africa
A recent landscape report on cancer care in nine MEA countries from the Swedish Institute for Health Economics (IHE) and the Pharmaceutical Research and Manufacturers of America (PhRMA) reveals that newly diagnosed cancer cases in MEA could almost double between 2020 and 2040 if immediate action isn’t taken to address the rising trend.